Published online before print May 19, 2005, doi: 10.1161/01.STR.0000169924.60783.d4
(Stroke. 2005;36:1410.)
© 2005 American Heart Association, Inc.
Original Contributions |
Markers of Endothelial and Hemostatic Activation and Progression of Cerebral White Matter Hyperintensities
Longitudinal Results of the Austrian Stroke Prevention Study
From Clinical Neuroscience (H.S.M.), St George’s Hospital Medical School, St George’s Hospital, London, UK; Haematology (B.H., K.P.), St Thomas’s Hospital, London, UK; and the Department of Neurology (C.E., R.S.) and Institute of Medical Molecular Biology and Biochemistry (H.S.), Medical University, Graz, Austria.
Correspondence to Hugh Markus, Clinical Neuroscience, St George’s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. E-mail h.markus{at}sghms.ac.uk
Background and Purpose— The pathogenesis of cerebral small vessel disease (SVD) is poorly understood, but endothelial activation and dysfunction may play a causal role. Cross-sectional studies have found increased circulating markers of endothelial activation, but this study design cannot exclude causality from secondary elevations. Confluent white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) appear to represent asymptomatic cerebral SVD. In a prospective study, we determined whether circulating markers of endothelial activation predicted progression of WMH.
Methods— In the community-based Austrian Stroke Prevention Study, MRI was performed at baseline in 296 subjects and repeated at 3 and 6 years. The following were measured on baseline plasma samples: intercellular adhesion molecule (ICAM), thrombomodulin, tissue factor plasma inhibitor, prothrombin fragments 1 and 2, and D-dimers.
Results— ICAM was associated with age- and gender-adjusted WMH lesion progression at both 3 and 6 years, respectively; (odds ratio [OR], 1.007; 95% confidence interval [CI], 1.002 to 1.012; P=0.004; and OR, 1.004; 95% CI, 1.000 to 1.009 per ng/mL; P=0.057). After multivariate analysis controlling for other cardiovascular risk factors and C-reactive protein, 3-year OR was 1.010 (95% CI, 1.004 to 1.017; P=0.001) and 6-year OR was 1.008 (1.002 to 1.014 per ng/mL; P=0.006). Baseline log lesion volume was a strong independent predictor of progression but associations remained after controlling for this (3-year OR, 1.011; 95% CI, 1.002 to 1.020; P=0.013; and 6-year OR, 1.009; 95% CI, 1.000 to 1.017; P=0.039 per ng/mL). There was no association between WMH progression and other markers.
Conclusions— ICAM levels are related to progression of WMH on MRI. The prospective study design increases the likelihood that this association is causal and supports a role of endothelial cell activation in disease pathogenesis. In contrast, we found no evidence for coagulation activation being important.
Key Words: cerebrovascular disorders • lacunar infarction • magnetic resonance imaging • risk factors • white matter
This article has been cited by other articles:
 |
|
 |
|
  G. Jickling, A. Salam, A. Mohammad, M. S. Hussain, J. Scozzafava, A. M. Nasser, T. Jeerakathil, A. Shuaib, and R. Camicioli Circulating Endothelial Progenitor Cells and Age-Related White Matter Changes Stroke, October 1, 2009; 40(10): 3191 - 3196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gomis, T. Sobrino, A. Ois, M. Millan, A. Rodriguez-Campello, N. P. de la Ossa, R. Rodriguez-Gonzalez, J. Jimenez-Conde, E. Cuadrado-Godia, J. Roquer, et al. Plasma {beta}-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype Stroke, October 1, 2009; 40(10): 3197 - 3201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gunstad, A. Benitez, K. F. Hoth, M. B. Spitznagel, J. McCaffery, J. McGeary, L. S. Kakos, A. Poppas, R. H. Paul, A. L. Jefferson, et al. P-Selectin 1087G/A Polymorphism Is Associated With Neuropsychological Test Performance in Older Adults With Cardiovascular Disease Stroke, September 1, 2009; 40(9): 2969 - 2972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kearney-Schwartz, P. Rossignol, S. Bracard, J. Felblinger, R. Fay, J.-M. Boivin, T. Lecompte, P. Lacolley, A. Benetos, and F. Zannad Vascular Structure and Function Is Correlated to Cognitive Performance and White Matter Hyperintensities in Older Hypertensive Patients With Subjective Memory Complaints Stroke, April 1, 2009; 40(4): 1229 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Baune, G. Ponath, M. Rothermundt, A. Roesler, and K. Berger Association Between Cytokines and Cerebral MRI Changes in the Aging Brain J Geriatr Psychiatry Neurol, March 1, 2009; 22(1): 23 - 34. [Abstract] [PDF]
|
|
|
|
 |
|
 K. C. Insel, S. L. Reminger, and C.-P. Hsiao White Matter Hyperintensities and Medication Adherence Biol Res Nurs, October 1, 2008; 10(2): 121 - 127. [Abstract] [PDF]
|
|
|
|
 |
|
 M van Oijen, E Y L Cheung, C E M Geluk, A Hofman, P J Koudstaal, M M B Breteler, and M P de Maat Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 799 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fornage, Y. A. Chiang, E. S. O'Meara, B. M. Psaty, A. P. Reiner, D. S. Siscovick, R. P. Tracy, and W.T. Longstreth Jr Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study Stroke, July 1, 2008; 39(7): 1952 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Gouw, W. M. van der Flier, F. Fazekas, E. C.W. van Straaten, L. Pantoni, A. Poggesi, D. Inzitari, T. Erkinjuntti, L. O. Wahlund, G. Waldemar, et al. Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period: The Leukoaraiosis and Disability Study Stroke, May 1, 2008; 39(5): 1414 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kimura, T. Sakurai, Y. Tanaka, I. Hozumi, K. Takahashi, M. Takemura, K. Saito, M. Seishima, and T. Inuzuka Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patient with white matter hyperintensities on brain MRI Lupus, January 1, 2008; 17(1): 16 - 20. [Abstract] [PDF]
|
|
|
|
 |
|
 H. S. Markus Genes, endothelial function and cerebral small vessel disease in man Exp Physiol, January 1, 2008; 93(1): 121 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Khatri, C. B. Wright, T. L. Nickolas, M. Yoshita, M. C. Paik, G. Kranwinkel, R. L. Sacco, and C. DeCarli Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) Stroke, December 1, 2007; 38(12): 3121 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmidt, H. Schmidt, M. Pichler, C. Enzinger, K. Petrovic, K. Niederkorn, S. Horner, S. Ropele, N. Watzinger, M. Schumacher, et al. C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease: Results of the Austrian Stroke Prevention Study Stroke, December 1, 2006; 37(12): 2910 - 2916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ladenvall, K. Jood, C. Blomstrand, S. Nilsson, C. Jern, and P. Ladenvall Serum C-Reactive Protein Concentration and Genotype in Relation to Ischemic Stroke Subtype Stroke, August 1, 2006; 37(8): 2018 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. W. Chen, M. E. Gurol, J. Rosand, A. Viswanathan, S. M. Rakich, T. R. Groover, S. M. Greenberg, and E. E. Smith Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology, July 11, 2006; 67(1): 83 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Munoz Leukoaraiosis and Ischemia: Beyond the Myth Stroke, June 1, 2006; 37(6): 1348 - 1349. [Full Text] [PDF]
|
|
|
|
|
|
A. Chamorro and J. Hallenbeck The Harms and Benefits of Inflammatory and Immune Responses in Vascular Disease Stroke, February 1, 2006; 37(2): 291 - 293. [Full Text] [PDF]
|
|